Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	9,086	9,568	3,575	514	95	70
Market Cap Growth	167.65%	167.65%	595.01%	443.89%	35.73%	-4.81%
Enterprise Value	9,007	9,415	3,504	520	199	165
Last Close Price	20.75	21.85	8.03	1.15	0.31	0.23
PE Ratio	94.32	99.92	19.28	11.67	12.60	37.04
PS Ratio	24.69	26.00	4.68	0.87	0.46	0.62
PB Ratio	14.46	15.23	6.20	2.03	0.58	0.45
P/TBV Ratio	14.46	15.23	6.20	2.03	0.58	0.45
P/FCF Ratio	175.56	184.87	-	-	1.47	-
P/OCF Ratio	114.75	120.83	-	16.23	1.18	12.97
EV/Sales Ratio	24.48	25.59	4.58	0.88	0.97	1.47
EV/EBITDA Ratio	53.18	55.59	16.18	8.01	6.78	9.38
EV/EBIT Ratio	64.65	67.58	17.87	11.17	15.63	58.82
EV/FCF Ratio	174.03	181.91	-	-	3.09	-
Debt / Equity Ratio	0.07	0.07	0.06	0.20	0.21	0.63
Debt / EBITDA Ratio	0.25	0.25	0.15	0.78	1.15	5.57
Debt / FCF Ratio	0.81	0.81	-	-	0.52	-
Asset Turnover	0.45	0.45	1.00	1.08	0.58	0.32
Inventory Turnover	1.32	1.32	16.28	12.78	3.73	1.81
Quick Ratio	1.21	1.21	2.89	1.00	0.62	1.46
Current Ratio	3.79	3.79	3.97	1.25	1.28	2.28
Return on Equity (ROE)	15.90%	15.90%	44.70%	21.16%	4.70%	1.21%
Return on Assets (ROA)	10.58%	10.58%	16.04%	5.29%	2.25%	0.51%
Return on Capital (ROIC)	13.63%	13.63%	26.88%	11.62%	3.53%	0.72%
Return on Capital Employed (ROCE)	20.00%	20.00%	30.80%	14.40%	5.60%	1.00%
Earnings Yield	1.05%	1.00%	5.19%	8.57%	7.94%	2.70%
FCF Yield	0.57%	0.54%	-1.95%	-2.57%	68.08%	-18.00%
Dividend Yield	0.48%	-	1.24%	1.09%	4.06%	-
Payout Ratio	45.73%	45.73%	0.38%	1.65%	-	-
Buyback Yield / Dilution	0.60%	0.60%	-551.03%	-7.38%	-	-0.02%
Total Shareholder Return	1.10%	0.60%	-549.78%	-6.29%	4.06%	-0.02%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.